The Federal Drug Administration approved a clinical trial to test the effectiveness of an electronic grid that records brain activity during surgery, developed by engineers at the University of California San Diego.
Agios’ tebapivat gets FDA orphan drug designation
Agios focuses on developing groundbreaking therapies for patients with rare diseases. Credit: kiehlord/Shutterstock. Agios Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has
September 12, 2024